75D30126P21326 JOFOC Award Notice_Redacted.pdf

Mortality data (Optional Task) that are linkable to the Comprehensive Healthcare Database at the patient level. The Contractor’s data and services shall fulfill CDC’s minimum requirements, described in the Statement of Work and summarized below.

The Contractor shall provide CDC with necessary license(s) for full and complete access to and use of the entire Comprehensive Healthcare Database. The database shall meet the minimum requirements and include the minimum data elements specified in the SOW.

The Contractor shall provide the minimum data elements for inpatient and hospital-based encounters within a single, integrated database, including facility data, patient and administrative data, visit-level diagnoses, procedures, medications, devices, and laboratory test data, itemized billing and chargemaster data, general laboratory results data, microbiology laboratory results data, vital measurement data, social determinants of health, and long-term mortality data (optional task). Drug utilization information shall be categorized by the day of stay, and the quantity, strength used, charge, and hospital reported costs. Admission and discharge dates (mm/dd/yyyy) shall be provided in a manner that protects personally identifiable information. Discharge status and discharge disposition, including ability to identify in-hospital deaths, will be provided.

The Comprehensive Healthcare Database shall be available historically from 2016 to current; include majority of healthcare encounters that occurred in the most recent 2-3 months; provide ability to track individual patients longitudinally within a hospital or health system; capture detailed medications, procedures, devices, and services provided in the healthcare setting; include weights to generate national inpatient estimates; and come from a representative sample of at least 1,400 geographically diverse non-profit, non-governmental, and community and teaching hospitals and health systems from rural and urban areas that capture at least 25% of U.S. hospital admissions.

The Social Determinants of Health (SDOH) data shall be linked based on the patients’ place of residence (not facility location) at the lowest (or smallest) level of geography allowable, align temporally to the patients’ visit, and include the following measures, at a minimum: American Community Survey average household size, median household income, income inequality, average educational level and CDC/ATSDR Social Vulnerability Index overall and for four themes.

Contractor shall deliver the cumulative (from 2016 through the most recent data available) shall deliver the data extracts in accordance CDC’s defined Data Transfer Protocol and Security requirements and provide available metadata and data dictionary as described in the SOW.

Contractor shall provide professional, expert-level, virtual training to CDC staff covering a range of introductory, intermediate, and advanced topics related to use and analysis of the licensed data. Contractor shall provide technical and scientific support to CDC staff and meet monthly with CDC Data Hub team.

Optional task: The Contractor shall provide CDC with necessary license(s) for full and complete access to Long-term Mortality data, which shall contain date of death for patients who died in-hospital or were identified as deceased through comprehensive mortality data sources. The Long-term mortality data table shall be linkable to the Comprehensive Healthcare Database at the patient level, contain information from 2016 through the most recent records available, and be updated and delivered to CDC monthly.

Period of Performance is for total of 5 years: September 21, 2026 to September 20, 2031, consisting of one 12-month base period and four 12-month option periods.

Base Year: [September 21, 2026] to [September 20, 2027] Option Period One: [September 21, 2027] to [September 20, 2028] Option Period Two: [September 21, 2028] to [September 20, 2029] Option Period Three: [September 21, 2029] to [September 20, 2030] Option Period Four: [September 21, 2030] to [September 20, 2031]

4. Statutory Authority Cited and Rationale:

FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. Authority: 41 U.S.C. 3304(a)(1). Per HHSAR 306.103-1, for acquisitions covered by 42 U.S.C. 247d-6a(b)(2)(A), “available from only one responsible source” must be deemed to mean “available from only one responsible source or only from a limited number of responsible sources.”

Premier Healthcare Solutions, Inc., is the only responsible source capable of satisfying all of CDC’s requirements. A core component of CDC’s requirements is for a single, integrated database containing detailed encounter-level administrative, healthcare utilization, and financial information data from standard hospital discharge billing files and line-item chargemaster records, as well as general and microbiology laboratory results and vital measurements data from electronic medical records, which is needed for CDC’s mission critical work. A second core component is that the database capture at least 25% of U.S. hospital admissions and include weights for generating national estimates. Premier Healthcare Solutions, Inc.’s proprietary Premier Healthcare Database (PHD) is the only commercially available database that meets all of CDC’s requirements.

Premier Healthcare Solutions, Inc. is one of the largest healthcare data and technology companies in the United States, serving a broad network of more than 4,250 member hospitals and health systems, including academic medical centers, integrated delivery networks, community hospitals, ambulatory surgery centers, physician practices, and other providers across virtually every region of the country. In addition to serving healthcare providers, Premier works extensively with government agencies, academic researchers, and regulatory organizations through its real-world evidence business. The company's longstanding partnerships with health systems have enabled it to build one of the most comprehensive and trusted hospital data ecosystems in the healthcare industry. Unlike most healthcare databases that rely primarily on claims, Premier's data are sourced directly from participating hospitals and integrate clinical, operational, financial, and supply chain information at the patient and encounter level. The database includes more than 20 years of longitudinal data representing approximately one-quarter of all U.S. inpatient admissions, over 1.3 billion outpatient visits, and more than 1,400 contributing hospitals, making it one of the largest and most comprehensive hospital-based real-world data repositories available. The Premier Healthcare Database uniquely combines detailed chargemaster information with administrative claims, electronic health record (EHR) data (including laboratory results and vital signs for participating sites), pharmacy records, purchasing and SKU-level supply chain data, and hospital operational metrics. This allows researchers to identify not only what diagnoses and procedures occurred, but also the specific drugs, devices, implants, and supplies used during each encounter, capabilities that are difficult or impossible to achieve with traditional claims databases alone.

CDC requires integrated pharmacy/medication, microbiology, general laboratory, and vital measurement data for monitoring antimicrobial resistance, sepsis, and other public health concerns. For example, to monitor trends in antimicrobial resistance, consistent hospitalization data with timing of clinical culture and associated susceptibility testing (microbiology and sensitivity data) is critical. To monitor sepsis and implement CDC’s adult sepsis event definition, CDC requires data that can identify if and when a blood culture was collected during a hospitalization (microbiology data), several general laboratory measures (e.g., creatinine, lactate, bilirubin), procedures and care level of patients (e.g., mechanical ventilation and intensive care unit status), and medications (e.g., vasopressor and antibiotic use). Measurement and risk-adjustment of important healthcare quality surveillance measures, such as hospital-onset bacteremia or non-ventilator hospital-acquired pneumonia, require detailed clinical information coupled with microbiology data to identify positive blood cultures, other laboratory results (e.g., white blood cell counts), and vital signs (e.g., temperature and oxygen saturation). Other projects to monitor health outcomes after cancer therapies also require vital signs, microbiology, and laboratory information and leverage mortality data from both inside and outside the hospital.

CDC requires an enterprise license and access to the proprietary Premier Healthcare Database to ensure continuity of mission critical surveillance and research. CDC has had an enterprise license for the PHD and access to associated tools, training, and technical assistance since 2020.

Continued access to the unique Premier Healthcare Database provided by this vendor is critical for CDC's ability to address a wide range of HHS and CDC priorities and to generate timely insights for mission critical emergency response and infectious disease surveillance and studies, including those described above. Additionally, retaining continuous access to a consistent data source allows for expedited analytics and the most efficient use of staff time because of familiarity with the database and its usage. Currently, there are >110 CDC staff across 11 CDC Centers and Offices using the PHD for one or more analytic projects. To date, CDC staff have published >50 scientific articles that used the PHD to advance public health knowledge and inform public health recommendations.

OPHDST/IDD/ADB has had one sole source and one competed contract for this acquisition requirement since 2020 supporting the COVID-19 public health emergency, post COVID-19 response, and other public health activities and priorities. This acquisition is for an enterprise (CDC-wide) license to access and analyze the Premier Healthcare Database, which OPHDST/IDD/ADB manages on behalf of the agency.

Lastly, it is critical that CDC license any proprietary data directly from the primary data provider, rather than through a third-party data aggregator or reseller. A direct award to Premier Healthcare Solutions, Inc. ensures that CDC will receive access to most timely and comprehensive data; using a third-party will limit availability of key data elements, delay delivery of data, require unnecessary data replication or transformations, and introduce security, privacy, and compliance risks. A direct award also ensures CDC’s ability to engage with Premier's clinical informatics, data science, and technical teams without reliance on intermediary organizations who are less informed about the data and related technology.

5. Special Considerations for Certain Contract Extensions or Bridge Contracts: Not Applicable

6. Actions to Increase Competition:

a. A Notice Was Not Published:

A notice has not yet been published. In accordance with FAR 5.201, the Government will publicize this proposed contract action on the Government Point of Entry (GPE) at SAM.gov. To reduce procurement lead time, as authorized by FAR 12.202(b), the Government will combine the presolicitation notice and solicitation into a single Combined Synopsis/Solicitation.

No exceptions under FAR 5.202 apply, and the Combined Synopsis/Solicitation will satisfy the publicizing requirements of FAR Part 5. In addition, the Combined Synopsis/Solicitation will serve as the Government's notice of intent and provide an opportunity for interested vendors to identify themselves as potential sources before contract award. In accordance with FAR 6.305, the Government will make this

Justification for Other Than Full and Open Competition publicly available on the GPE (SAM.gov) within 14 days after contract award.

b. Responses Were Not Received:

Because the Combined Synopsis/Solicitation has not yet been published, no responses to a formal synopsis or solicitation have been received. A Request for Information (RFI) was published on July 6, 2026, to which CDC received seven (7) responses. As detailed in Section 7 (Market Research), none of the respondents demonstrated the ability to meet the Government's minimum requirements.

c. Sources Expressing Interest:

The only sources to express written interest to date were the seven (7) respondents to the RFI issued via the GSA e-Buy platform on July 6, 2026 and the RFI closed on July 14, 2026. Because the RFI was limited to GSA schedule holders, participation was restricted to vendors on those schedules. The Government will fully consider all proposals received in response to the forthcoming, Combined Synopsis/Solicitation on the GPE (SAM.gov).

d. Actions to Foster Competition for Future, Similar Requirements:

CDC will continue to evaluate the healthcare data market, specifically for hospital billing and chargemaster data and microbiology and susceptibility laboratory results data, before future acquisitions. Specific actions will include annual review of the healthcare data portfolio through CDC Data Hub governance processes; continued evaluation of emerging healthcare data alternatives; periodic market research and RFIs or sources-sought notices; and comparison of vendors against CDC’s requirements for available data elements, population coverage, timeliness, update frequency, enterprise access, analytic readiness, data quality, usability, and cost.

If another source becomes capable of satisfying CDC’s minimum requirements in the future, CDC will reassess the acquisition strategy and seek competition to the maximum extent practicable.

7. Market Research:

CDC conducted extensive market research to determine whether any source other than Premier Healthcare Solutions, Inc. could meet the agency’s minimum requirements for a single, integrated database containing detailed encounter-level administrative, healthcare utilization, and financial data from at least 25% of U.S. hospital admissions with weights for generating national estimates, as well as general and microbiology laboratory results and vital measurements data. Market research included input from subject matter experts in CDC’s Healthcare Data Portfolio Workgroup, website reviews of known healthcare data providers, and the RFI process.

In July 2025, CDC convened the Healthcare Data Portfolio Workgroup with representatives from CIOs that use healthcare data assets. The Workgroup identified three unique types (or sources) of healthcare data that are needed to address the breadth of CDC’s work: closed claims, electronic health records, and billing and chargemaster data. The Workgroup also identified priority attributes of healthcare data needed for CDC programs to fulfill their public health missions. These attributes included: high data quality, timeliness, representativeness, cost effectiveness, granularity, ease of use, consistency, availability, versatility, and non-redundancy.

The Workgroup then developed a crosswalk to compare healthcare data assets across the key attributes. The Premier Healthcare Database (PHD) is the only billing and chargemaster data asset in CDC’s healthcare data portfolio. It was identified as high priority to retain due to availability of detailed encounter-level administrative, healthcare utilization, and financial information data from standard hospital discharge billing files and line-item chargemaster records that are not available in EHR or claims data. In addition, the PHD includes general and microbiology laboratory results and vital measurements data from electronic medical records within a single, integrated database. The PHD also met nearly all of the priority data attributes:

high quality, timely, representative including availability of national weights, granular procedure, diagnosis, and medication data, cost effective, easy to use, widely used, versatile, and available consistently for CDC staff and program use.

CDC also conducted internet-based research and reviewed websites of known healthcare data providers, including Premier Healthcare Solutions, Meridian Data Pro, Cerner Federal Solutions, Clarify Health Solutions, Inc., Prognos Health, Optum, and other healthcare data, analytics, and platform providers. CDC identified multiple vendors that offer administrative data (hospital discharge, billing, claims), clinical data (EHR), pharmacy data, and analytics services. However, none of the vendors reviewed internally, except for Premier Healthcare Solutions, Inc., demonstrated the combination of full capabilities required by CDC. The findings are documented in the Market Research Report.

A Request for Information (RFI) titled “Hospital Encounter Billing and Chargemaster Data” was published through GSA on July 6, 2026 and closed on July 14, 2026.

CDC received 7 responses to the RFI, 5 Small Business (SB) and 2 Other Than Small Business (OTSB). No Service-Disabled Veteran-Owned Small Business (SDVOSB) responded to the RFI.

The responses were reviewed by CDC scientific, technical, and program staff against the minimum requirements in the Statement of Work. The RFI included a series of yes/no questions and the option to submit additional information in a capability statement; both inputs were considered in our capability assessment.

Based on our review, none of the 7 respondents demonstrated the capability to fulfill all of the SOW requirements. Three respondents demonstrated expertise in information technology, cybersecurity, management consulting, or related professional services; their capabilities did not align with the SOW's requirement to provide a comprehensive hospital encounter-level billing and chargemaster data solution. The remaining respondents proposed healthcare data assets or partnerships but did not demonstrate the ability to satisfy key SOW requirements, including required data content, hospital coverage, historical data availability, data recency, or technical support. Two respondents proposed electronic health record (EHR)-based or health information exchange (HIE)-based data sources that did not demonstrate access to the hospital billing and chargemaster data required by the SOW. Two other respondents proposed hospital chargemaster data source(s) and explicitly acknowledged that they could not provide required microbiology data elements and national inpatient weights. Collectively, these capability gaps indicate that none of the respondents demonstrated the ability to provide the integrated hospital data solution necessary to support CDC's surveillance, analytic, and public health response activities.

High-level summary of responses received

3 vendors did not address the SOW requirements or demonstrate ability to meet the requirements; two of the three explicitly stated in response to RFI questions that they could not meet specific SOW requirements.

2 vendors proposed an approach and/or data partner that relied on electronic health record (EHR)-based or health information exchange (HIE)-based data sources, which do not meet CDC’s requirements to provide detailed, line-item billing and chargemaster data for all services, procedures, devices, and drugs.

2 vendors proposed a data partner that is not able to meet specific, critical SOW requirements for microbiology data elements (i.e., organism identification, drug tested, and antimicrobial susceptibility results) and national inpatient weights.

Premier Healthcare Solutions, Inc. is the only evaluated vendor that currently provides the required capability. The government has had two previous contracts (including current contract that ends August 31, 2026) with Premier Healthcare Solutions, Inc. for a total of six years.

Premier Healthcare Solutions, Inc. has demonstrated the capability to perform all the required tasks in the SOW. Specifically, they provide CDC with an enterprise license to and monthly extracts of their proprietary Premier Healthcare Database, which address the SOW’s minimum requirements for a single, integrated hospital-based outpatient billing and chargemaster database with general and microbiology laboratory results and vital measurements data;

capture 25% of U.S. hospital admissions; weights for national inpatient estimates; supplemental social determinants of health data; and availability of long-term mortality data.

Whereas several vendors can provide some of the detailed encounter-level billing and chargemaster data or microbiology laboratory results data, none of the respondents to the RFI nor any vendor identified in CDC’s internal market research, can provide both in a single, integrated database that meets all the requirements in the SOW related to historical data, hospital capture, timeliness, and national weights.

Based on this market research, CDC has determined that Premier Healthcare Solutions, Inc. is the only source currently capable of satisfying the agency’s full requirements. CDC will continue market research before future acquisitions and will reassess our minimum requirements, and whether other vendors, data networks, health information exchanges, or query/pull models become capable of meeting CDC’s requirements.

8. Procurement History:

Contractor: Premier Healthcare Solutions, Inc.

Contract or Order Number: 75D30120P09677 Award Date and Period of Performance: Award date 08/27/2020 and Period of Performance 09/01/2020 – 08/31/2023 Value (including all options): $225,000.00 Competitive Status: Not Competed - Sole Source Authority formerly relied upon FAR 13.106-1(b)(1); “only one source [is] reasonably available” which states that, “For purchases not exceeding the simplified acquisition threshold. (i) Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available.

Contractor: Premier Healthcare Solutions, Inc.

Contract or Order Number: 75D30123C16644 Award Date and Period of Performance: Award date 08/21/2023 and Period of Performance 09/01/2023 – 08/31/2026 Value (including all options): $1,842,580.00 Competitive Status: Competed – Full and Open Competition A total of two (2) proposals were received; one from Premier and another offeror. The other offeror’s proposal overall was determined to be unacceptable for award. The Contracting Officer determined that an award to Premier represented the best value to the Government. As a result, the Contracting Officer decided to make a single award to Premier.

9. Additional Information or Other Facts:

CDC has had contracts with Premier Healthcare Solutions, Inc. for enterprise data since September 2020.

Over >110 CDC staff across 11 CDC Centers/Institutes/Offices use Premier data for a multitude of data analytic projects. All data access and analytic projects will be terminated at the end of the current contract period of performance in the absence of a new contract. As stated earlier, CDC’s Healthcare Data Portfolio Workgroup recommended continuation of Premier Healthcare Solutions, Inc. as the agency’s selected enterprise billing and chargemaster data assets. CIO Directors endorsed the Workgroup recommendations and agreed to participate in a FY26 cost share to provide continued access to this prioritized data asset.

At the same time, the complexity of available healthcare data and vendor delivery platforms makes transitioning from one data source to another time-, effort-, and labor-intensive. Developing a deep understanding of a detailed billing and chargemaster data source requires substantial investment from data scientists, analysts, and program staff, particularly when teams have already built subject-matter expertise, documentation, analytic methods, and established data pipelines around the current source.

Accordingly, CDC should consider not only the direct cost of any new data source, but also the operational burden associated with learning the data structure, validating outputs, rebuilding or modifying pipelines, updating documentation, and ensuring continuity in reporting and analysis. Given this level of effort, any change in data source should be supported by clear evidence that the new source provides substantial added value, materially improves mission support, or addresses a critical limitation of the existing source.

10. Technical or Requirements Program Management Certification: I certify that the supporting data under my cognizance which are included in the justification are accurate and complete to the best of my knowledge and belief. (Always required.)

Tegan Boehmer Chief, Actionable Data Branch

IDD, OPHDST, CDC

Signature & Date:

11. Fair and Reasonable Price Determination: As the contracting officer, I hereby determine that the anticipated price to the Government for this contract action will be fair and reasonable.

This determination will be made using the following: cost analysis price analysis cost realism market pricing historical pricing other: A commercial item is being acquired. The Government will rely on information other than certified cost or pricing data, including commercial sales practices, published price lists, and the contractor's internal pricing policies for similar commercial licenses, to ensure a fair and reasonable price.

As a part of this basis, certified cost, or pricing data (see FAR 15.403)— will be required. will not be required and the following FAR part 15 exception applies:

Prices that will be agreed upon are based on adequate price competition.

Prices that will be agreed upon are based on prices set by law or regulation.

A commercial item is being acquired.

A waiver has been granted by the HCA in accordance with FAR 15.403-2(c)(4).

The contract action is a modification to a contract or subcontract for commercial item(s).

The estimated cost of the contract action is less than the threshold for certified cost or pricing data.

12. Contracting Officer (CO) Certification and Determination: I hereby certify that this justification is accurate and complete to the best of my knowledge and belief. And, based upon the foregoing, I also determine that using a sole-source contract is in the best interest of CDC.

(Always required; CO approval authority is limited to $900,000.)

Latoya Michel Contracting Officer Signature & Date:

ELEVATED REVIEWS & APPROVALS

13. CDC Advocate for Competition (AfC) Review and Approval: I reviewed this justification find that it adequately supports other than full and open competition. (Division AfC approval authority is limited to $20,000,000.)

Terrance Perry Deputy Chief Financial Officer and Deputy Director, Office of Financial Resources (OFR)

Signature & Date:

14. CDC Head of the Contracting Activity (HCA) Review and Approval: I reviewed this justification and find that it adequately supports other than full and open competition. (Division HCA approval authority is limited to $90,000,000.)

Christine Godfrey Head of the Contracting Activity Signature & Date:

15. HHS Office of General Counsel Review and Concurrence: I reviewed this justification and concur that it adequately supports other than full and open competition. (Mandatory when SPE approval is required.)